Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis. [electronic resource]
Producer: 20120730Description: 2522-32 p. digitalISSN:- 1538-7445
- Animals
- Antineoplastic Agents, Alkylating -- adverse effects
- Bone Marrow -- drug effects
- Bone Neoplasms -- secondary
- Cell Line, Tumor
- Chemokine CCL2 -- pharmacology
- Cyclophosphamide -- adverse effects
- Docetaxel
- Humans
- Interleukin-6 -- pharmacology
- Male
- Mice
- Myeloid Cells -- drug effects
- Neoplasm Transplantation
- Prostatic Neoplasms -- pathology
- Taxoids -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.